Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Insole ODM factory in Thailand

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Indonesia pillow OEM manufacturer

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Taiwan ergonomic pillow OEM factory supplier

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Private label insole and pillow OEM production factory

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Thailand custom product OEM/ODM services

New research has revealed that memory formation in the brain is likely due to the formation of new connections between engram cells, emphasizing the importance of synaptic wiring changes in learning and memory storage. What mechanism allows our brains to incorporate new information and form memories? Research led by Dr. Tomás Ryan from Trinity College Dublin reveals that learning involves the ongoing creation of new connections between specific engram cells across various brain regions. We are always learning, either intentionally, incidentally, or accidentally, causing continuous changes in our brains. Our interactions with the world, each other, and media content lead to the acquisition of new information and the creation of memories. The next time we walk down the street, meet our friends, or come across something that reminds us of the last podcast we listened to, we will quickly re-engage that memory information somewhere in our brains. But how do these experiences modify our neurons to allow us to form these new memories? The Brain’s Dynamic Networks Our brains are organs composed of dynamic networks of cells, always in a state of flux due to growing up, aging, degeneration, regeneration, everyday noise, and learning. The challenge for scientists is to identify the “difference that makes a difference” for forming a memory – the change in a brain that stores a memory is referred to as an ‘engram’, which retains information for later use. This newly published study aimed to understand how information may be stored as engrams in the brain. Dr Clara Ortega-de San Luis, Postdoctoral Research Fellow in the Ryan Lab and lead author of the article published in the leading international journal, Current Biology, said: “Memory engram cells are groups of brain cells that, activated by specific experiences, change themselves to incorporate and thereby hold information in our brain. Reactivation of these ‘building blocks’ of memories triggers the recall of the specific experiences associated with them. The question is, how do engrams store meaningful information about the world?” To identify and study the changes that engrams undergo that allow us to encode a memory, the team of researchers studied a form of learning in which two experiences that are similar to each other become linked by the nature of their content. The researchers used a paradigm in which animals learned to identify different contexts and form associations between them. By using genetic techniques the team crucially labeled two different populations of engram cells in the brain for two discrete memories and then monitored how learning manifested in the formation of new connections between those engram cells. Findings and Implications of the Research Then using optogenetics, which allows brain cell activity to be controlled with light, they further demonstrated how these newly formed connections were required for the learning to occur. In doing so, they identified a molecular mechanism mediated by a specific protein located in the synapse that is involved in regulating the connectivity between engram cells. This study provides direct evidence for changes in synaptic wiring connectivity between engram cells to be considered as a likely mechanism for memory storage in the brain. Commenting on the study, Dr Ryan, Associate Professor in Trinity’s School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, and the Trinity College Institute of Neuroscience, said: “Understanding the cellular mechanisms that allow learning to occur helps us to comprehend not only how we form new memories or modify those pre-existent ones, but also advance our knowledge towards disentangling how the brain works and the mechanisms needed for it to process thoughts and information. “In 21st-century neuroscience, many of us like to think memories are being stored in engram cells, or their sub-components. This study argues that rather than looking for information within or at cells, we should search for information between cells, and that learning may work by altering the wiring diagram of the brain – less like a computer and more like a developing sculpture. “In other words, the engram is not in the cell; the cell is in the engram.” Reference: “Engram cell connectivity as a mechanism for information encoding and memory function” by Clara Ortega-de San Luis, Maurizio Pezzoli, Esteban Urrieta and Tomás J. Ryan, 21 November 2023, Current Biology. DOI: 10.1016/j.cub.2023.10.074 The study was funded by the Irish Research Council, the US National Institute of Health, the European Research Council, and Science Foundation Ireland.

The new tool has the potential to improve gene and cell therapies. A New Tool for Safer Gene Therapy Scientists at St. Jude Children’s Research Hospital have developed a tool that can locate safe places to introduce genes into human DNA. The tool is an early step in the process of improving the safety and effectiveness of gene and cell therapies. The research was recently published in the journal Genome Biology.  “We’ve created the Google Maps of editing the genome,” said co-corresponding author Yong Cheng, Ph.D., St. Jude Department of Hematology. “With this tool, we provide a new approach to identify places to safely integrate a gene cassette. We created step-by-step directions, so you can follow the steps and easily find safe harbor sites in specific tissues.” Gene therapy, in which a patient is given a functioning copy of a dysfunctional gene, has demonstrated success in treating some genetic disorders. However, there have been safety concerns in the field, such as the unintentional activation of an oncogene that caused cancer in some patients. As a result, scientists have looked for “safe harbor sites” in the genome, or locations where a gene may be introduced without causing cancer or other issues. The researchers developed a pipeline that searches for safe harbor sites using genomic and epigenetic information from specific tissues, such as blood cells. Co-first author Dewan Shrestha (left), corresponding author Yong Cheng, Ph.D. (center), and co-author Ruiqiong Wu (right). Credit: St. Jude Children’s Research Hospital A Novel Way To Find Safe Harbor Sites The tool compares the DNA sequences that are highly variable between healthy people, using data from the 1000 Genomes Project. The researchers reasoned that if a DNA region is often deleted or inserted in healthy individuals, it could probably also be safely modified by gene therapy. “Our method is a new way to identify genomic safe harbor sites in a tissue-specific manner,” Cheng said. “Nobody has tried it from this angle. Our first step was to find the genomic loci that show a high frequency of insertion or deletion among healthy individuals.” If DNA in a single cell was a string, it would be two meters long. But in addition to the linear sequence, DNA can loop into complex 3D structures using chromatin, the proteins associated with DNA, to fit within a cell. Just like a string, DNA can have loops that affect its function. The St. Jude tool considers the presence of these loops and other structures when searching for accessible safe harbor sites. “Our tool assesses the 3D structure of DNA because human DNA is not a one-dimensional linear structure, it’s actually 3D,” Chen said. “So, parts of DNA may be far away in the linear sequence of DNA but may physically be next to each other because of the looping of the 3D structure. In that case, the 3D proximity is more important than the linear distance.” Balancing Safety and Therapeutic Gene Expression “Safe gene therapy requires two things,” said Cheng. “Number one, maintaining high expression of the new gene. And number two, the integration needs to have minimal effects on the normal human genome, which is a major concern for people performing gene therapy.” The scientists found that the genes placed in safe harbor sites identified by their tool maintained their expression over time. The researchers also showed that if they put a gene into one of the safe harbor sites identified by their tool, it affected nearby genes less than a classic safe harbor site. The tool called the Genomics and Epigenetic Guided Safe Harbor mapper (GEG-SH mapper) is freely available. Reference: “Genomics and epigenetics guided identification of tissue-specific genomic safe harbors” by Dewan Shrestha, Aishee Bag, Ruiqiong Wu, Yeting Zhang, Xing Tang, Qian Qi, Jinchuan Xing and Yong Cheng, 21 September 2022, Genome Biology. DOI: 10.1186/s13059-022-02770-3k The study was funded by the National Institutes of Health and the National Cancer Institute.

Treatment with bioavailable small-molecule pharmacochaperones targeting the visual receptor rhodopsin offers a promising approach to prevent retinal photoreceptor degeneration caused by inherited mutations in this receptor. Credit: Beata Jastrzebska, created from images on Pixabay by justDIYteam and WikimediaImages (CC-BY 4.0) A new study reveals the potential of two compounds in treating retinitis pigmentosa, a blinding genetic disorder. These compounds, identified through virtual screening, have shown promising results in stabilizing rhodopsin protein and preventing retinal degeneration in animal models. Breakthroughs in Retinitis Pigmentosa Treatment Researchers have identified two promising compounds that may help treat retinitis pigmentosa, a group of inherited eye disorders that lead to blindness. The discovery, published today (January 14th) in the open-access journal PLOS Biology, was led by Beata Jastrzebska from Case Western Reserve University, USA, and her team. These compounds were uncovered using a virtual screening technique. Retinitis pigmentosa occurs when genetic mutations cause the retinal protein rhodopsin to misfold, resulting in the death of retinal cells and progressive vision loss. Approximately 100,000 people in the United States are affected by this condition, creating an urgent need for treatments that can correct rhodopsin misfolding. Existing experimental therapies often rely on retinoid compounds, such as synthetic vitamin A derivatives. However, these treatments are highly sensitive to light and can be toxic, limiting their effectiveness and safety. Virtual Screening and Compound Discovery In the new study, researchers utilized virtual screening to search for new drug-like molecules that bind to and stabilize the structure of rhodopsin to improve its folding and movement through the cell. Two non-retinoid compounds were identified that met these criteria and had the ability to cross the blood-brain and blood-retina barriers. The team tested the compounds in the lab and showed that they improved cell surface expression of rhodopsin in 36 of 123 genetic subtypes of retinitis pigmentosa, including the most common one. Additionally, they protected against retinal degeneration in mice with retinitis pigmentosa. Promising Results and Future Directions “Importantly, treatment with either compound improved the overall retina health and function in these mice by prolonging the survival of their photoreceptors,” the authors say. However, they note that additional studies of the compounds or related compounds are needed before testing the treatments in humans. The authors add, “Inherited mutations in the rhodopsin gene cause retinitis pigmentosa (RP), a progressive and currently untreatable blinding disease. This study identifies small molecule pharmacochaperones that suppress the pathogenic effects of various rhodopsin mutants in vitro and slow photoreceptor cell death in a mouse model of RP, offering a potential new therapeutic approach to prevent vision loss.” Reference: “Discovery of non-retinoid compounds that suppress the pathogenic effects of misfolded rhodopsin in a mouse model of retinitis pigmentosa” by Joseph T. Ortega, Jacklyn M. Gallagher, Andrew G. McKee, Yidan Tang, Miguel Carmena-Bargueňo, Maria Azam, Zaiddodine Pashandi, Marcin Golczak, Jens Meiler, Horacio Pérez-Sánchez, Jonathan P. Schlebach and Beata Jastrzebska, 14 January 2025, PLOS Biology. DOI: 10.1371/journal.pbio.3002932

DVDV1551RTWW78V